Xenon Pharmaceuticals Inc.
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Equivalents | $20.5M | $17.1M | $58.7M | $72.0M | $38.0M |
| Accounts Receivable | $438.0K | $200.0K | $315.0K | $215.0K | $440.0K |
| Inventory | — | — | — | — | — |
| Total Current Assets | $44.8M | $65.7M | $60.9M | $84.9M | $49.9M |
| Property, Plant & Equipment | $1.1M | $1.4M | $2.0M | $2.5M | $1.9M |
| Goodwill | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — |
| Total Assets | $46.1M | $67.5M | $63.9M | $87.4M | $54.5M |
| Liabilities | |||||
| Accounts Payable | $1.3M | $1.5M | $1.1M | $553.0K | $391.0K |
| Total Current Liabilities | $4.1M | $3.6M | $2.8M | $14.3M | $18.2M |
| Long-Term Debt | $6.1M | — | — | — | — |
| Total Liabilities | $10.2M | $3.6M | $2.9M | $14.6M | $30.4M |
| Stockholders' Equity | |||||
| Retained Earnings | $-173.4M | $-142.7M | $-119.7M | $-103.7M | $-116.8M |
| Total Stockholders' Equity | $35.9M | $63.9M | $61.0M | $72.8M | $-78.4M |